Sleep and sleep disorders - PowerPoint PPT Presentation

1 / 73
About This Presentation
Title:

Sleep and sleep disorders

Description:

Sleep and sleep disorders Andy Montgomery – PowerPoint PPT presentation

Number of Views:157
Avg rating:3.0/5.0
Slides: 74
Provided by: andym
Category:

less

Transcript and Presenter's Notes

Title: Sleep and sleep disorders


1
Sleep and sleep disorders
  • Andy Montgomery

2
Talk Outline
  • Normal Sleep
  • Diagnosing sleep disorders
  • Insomnia
  • Hypersomnia
  • Parasomnias
  • Circadian sleep rhythm disorders
  • Psychiatric disorders and sleep
  • Pharmacology and sleep

3
Normal sleep
  • 1/3 of adult lives asleep
  • Role poorly understood
  • Sleep deprivation consequences
  • Cognitive impairment
  • Hormonal rhythm disturbance
  • Rebound after deprivation

4
Normal sleep
  • Quantity
  • 7-8 hours
  • lt6 increased reports dissatisfaction
  • Control by 2 processes
  • Circadian process
  • Homeostatic process

5
The Circadian process
  • 24 hour cycle
  • Many cells and organs
  • Principle time-keeper
  • Supra-chiasmatic nucleus
  • Influenced by light and temperature
  • Some sleep disorders associated with genetic
    variant
  • Determines owl/lark

6
The homeostatic process
  • Aka recovery drive to sleep
  • Increases in proportion to time awake
  • 2 processes interact
  • Generates
  • Post-lunch dip
  • mid-evening activity
  • Other influences
  • Arousal, relaxation, anxiety

7
Physiology of sleep control
  • Orexin (hypocretin)
  • Peptide hormone
  • Promotes wakefulness
  • Wakefulness
  • Ascending arousal system dominant
  • Sleep
  • Inhibition of arousal systems

8
Sleep structure
  • Polysomnography
  • Simultaneous record
  • EEG
  • Muscle activity
  • Eye movements
  • 4-5 cycles
  • Quiet sleep alternating with REM
  • Increased duration through night

9
Hypnogram
10
Sleep structurequiet sleep
  • 4 stages
  • 1 dozing just resting eyes
  • 2 deeper, occasional jerks, reduced HR RR
  • 34 slow HR RR
  • EEG
  • Progressive slow synchronous activity
  • Reduced cortical arousal
  • Increased thalamo-cortical synchrony

11
Sleep structureREM
  • Rapid onset
  • EEG awake
  • Jerky eye movements
  • Muscle paralysis
  • Autonomic arousal
  • Usually several short wakenings

12
Stage EEG Eye movt EMG
Wake Low-amp, mixed some alpha Many varied, usually fast High
1 Low amp, mainly irregular theta Slow rolling lateral movt Slightly lowered
2 Sleep spindles, K complexes low amp theta None Lowered
3 High amp delta, K complexes None Low
4 As 3 None Low
REM Low amp irregular, saw-toothed Rapid jerky, lateral absent
13
Age variants
  • 24 hour rhythm
  • Develops at 3/12
  • High levels REM in childhood
  • Aging
  • Time awake increases
  • Slow wave reduces
  • GH release reduces

14
Dreaming
  • Only remembered if REM followed by wakefulness
  • Occurs in
  • REM
  • Bizarre, storyline
  • Slow wave

15
Sleep and cognition
  • Sleep enhances memory consolidation
  • Transfer from short-term to long-term memory
  • Dependent on hippocampal activity
  • Sleep deprivation associated with reduced
    hippocampal neurogenesis

16
Sleep disorders
  • Diagnosis
  • Take sleep history
  • Questionnaires and diaries can be helpful
  • Sleep centres polysomnography, actigraphy, video
    recording
  • Classified in ICD 10 and DSM IV
  • 3 categories
  • Insomnia
  • Hypersomnia
  • Parasomnia

17
Questions to ask
  • Time
  • Bed, getting up, ?regular pattern
  • Falling asleep
  • Waking episodes
  • Quality (Pittsburgh Sleep Quality Index)
  • How many bad nights/week?

18
Questions to ask
  • Naps during day
  • Mood
  • Motor activity during sleep
  • Behaviour during sleep
  • Day-time somnolence (Epworth sleepiness scale)
  • Snoring
  • Use of drugs

19
Investigations
  • Actigraphy
  • Monitors movement via wrist band
  • Can be used over days- weeks
  • Sleep- less movement
  • Overnight video recording

20
Actigraphy
21
Polysomnography
  • Terms
  • Time in bed
  • Sleep onset (to stage 1 or 2)
  • Sleep onset latency
  • Sleep period onset to wake
  • Total sleep time
  • Number of wakenings
  • Sleep efficiency (total sleep/time in bed)
  • Wake after sleep onset
  • REM onset latency
  • Time in each sleep stage

22
Insomnia
  • Major public health problem
  • 10-15 adults persistent insomnia
  • Low quality of life
  • Increased absenteeism
  • Physical illness
  • Mental illness

23
Insomnia
  • Symptoms
  • Too little
  • Too long to go to sleep
  • Poor quality
  • Unrefreshing
  • Impaired daytime function
  • Daytime sleepiness uncommon (circadian rhythm
    disorder)

24
Insomnia
  • Two main types
  • Sleep onset insomnia
  • Sleep maintenance insomnia

25
Insomnia - precipitating factors
  • Psychiatric disorder
  • Depression
  • anxiety
  • Pharmacological
  • ?-blocker
  • AD
  • Caffeine
  • Alcohol
  • Stimulants
  • Withdrawal
  • Psychological stress
  • Bereavement
  • Increased arousal
  • Worry about alarm
  • Noise
  • children

Short term insomnia
  • Physical
  • Pain
  • Pregnancy
  • Illness (cardio/resp)
  • Urinary
  • Sleep wake cycle
  • jet lag
  • Shift work
  • Irregular routine

26
Insomnia- perpetuation
27
Insomnia- treatment
  • Establish primary diagnosis
  • Acknowledge distress
  • Treat precipitating factors/primary cause
  • Educate about trigger factors and reassure
  • Establish good sleep habits

28
Insomnia- treatmentHypnotics
  • Act at GABA-A benzodiazepine receptor
  • Generally safe and effective in short term
  • SE
  • Muscle relaxation
  • Memory impairment
  • Ataxia
  • Potentiated by EtOH
  • Avoid long term px

29
Insomnia- other drugs
  • Sedative AD
  • Mirtazapine
  • Agomelatine
  • Melatonin
  • Anti-histamines

30
Psychological treatments
  • Sleep hygiene
  • Regular hours
  • Daytime exercise
  • Morning daylight exposure
  • Reduced daytime napping
  • Avoid stimulants
  • Bed-time routine

31
Psychological treatments
  • Behavioural techniques
  • Stimulus control
  • Avoid clock watching
  • Dont watch TV
  • Dont stay in bed if awake
  • Sleep restriction
  • Relaxation training

32
Psychological treatments
  • Cognitive techniques
  • CBT
  • Avoid negative thoughts associated with not
    sleeping
  • Rehearsal and planning session
  • Paradoxical intent

33
Sleep restriction
34
Hypersomnia
  • Feeling sleepy during day
  • Distinct from tired
  • 37 adults a few days a month
  • 16 a few days / week
  • Main causes
  • Fragmentation of sleep
  • Obstructive sleep apnoea
  • Intrusion of sleep phenomena into wake
  • narcolepsy
  • Disturbed circadian rhythm.

35
Obstructive sleep apnoea symptoms
  • Excessive daytime sleepiness
  • Loud snoring
  • Interruptions of breathing
  • Resumes with loud gasp, violent movement
  • Marital problems
  • Dry mouth, sore throat, headache
  • Depression
  • Present in 0.5 men BMI gt25

36
Obstructive sleep apnoea treatment
  • Weight loss
  • Continuous positive pressure ventilation
  • Consider modafinil if remain sleepy during day

37
Narcolepsy
  • 3-4/10,000
  • HLA DQB10602 (18-35 in controls)
  • Symptoms
  • Sudden onset sleep
  • Sleepiness
  • Cataplexy
  • Hypnogogic/pompic hallucinations
  • Poor nocturnal sleep

38
Narcolepsy
  • Cause
  • Lack of orexin neurones/release in hypothalamus
  • Possible cross-reaction autoimmune disorder after
    infection in adolescence
  • Diagnosis
  • Clinical picture
  • Reduced REM latency

39
Narcolepsy
  • Treatment
  • Education
  • Day-time naps
  • Drugs
  • Daytime sleepiness
  • Modafinil/dexamphetamine
  • Cataplexy
  • 5HT enhancing drug SSRI, clomipramine
  • Night-time sleep disruption
  • Sodium oxybate

40
Other causes of daytime sleepiness
  • Idiopathic hypersomnia
  • Kleine-Levine syndrome
  • Rare, reversible disorder
  • Hypersomnia /- excessive eating hypersexuality
  • Onset adolescence
  • Typical duration 4-8 years
  • ? autoimmune

41
Parasomnias
  • Unusual behaviours occurring during sleep
  • Exacerbated by anxiety
  • Variable drug treatments

42
Night terrors
  • Recurrent episodes of abrupt waking usually first
    1/3 of night
  • Intense fear and autonomic arousal
  • Unresponsive to comforting
  • No detailed recall
  • Significant distress

43
Night terrors
  • Occur in 30-40 children
  • Generally resolve with aging
  • Can recur at times of stress
  • Comorbidity with anxiety common
  • Often run in families

44
Night terrors
  • Cause
  • Genetic component
  • Incomplete arousals from SW sleep
  • Treatment
  • Clonazepam
  • Paroxetine (immediate effect)

45
Night terrors hypnogram
46
Parasomnias -SWS
  • Sleep walking
  • Automatic behaviour
  • No recall
  • 15-20 lifetime prevalence
  • Confusional arousals
  • Semi-purposeful movements
  • Sleep bruxism
  • Sleep talking

47
Parasomnias -REM
  • Nightmares
  • Wake oriented (vs night terrors)
  • Association with depression and PTSD
  • Psychological treatment
  • Guided imagery- rehearse happy endings
  • Sleep paralysis
  • Waking with fear, foreboding, unable to move
  • Common-25 experience
  • Treatment- good sleep hygiene

48
Parasomnias -REM behaviour disorder
  • Violent, short duration
  • Several episodes/night
  • Can wake
  • Remembers dream
  • Violent unpleasant content
  • Strong association with subsequent IPD OR LBD
    (45-85)
  • Made worse by AD
  • Treat by making sleep environment safe

49
Circadian rhythm sleep disorders
  • Jet lag
  • Worse for travel east (natural clock 24.5hr)
  • Melatonin may help
  • Delayed sleep phase syndrome
  • Unable to sleep before 2-3AM
  • Preferred wake time after 10 AM
  • Causes insomnia and sleepiness on work days
  • Advanced sleep phase disorder
  • rare

50
Circadian rhythm sleep disorders
  • Non 24hr circadian sleep disorder
  • Sleep pattern advances daily
  • Most common in congenitally blind
  • Irregular sleep wake rhythm
  • Seen in dementia- ? Loss of melatonin neurons in
    SCN
  • Shift work sleep disorder

51
Sleep and depression
  • Sleep disturbance common in depression
  • Almost 100 some disturbance
  • Depression common in insomnia
  • 14-21 c/o insomnia depressed
  • 9 c/o hypersomnia depressed
  • 1 no sleep problem depressed
  • Depression most common diagnosis associated with
    insomnia

Epidemiologic study of sleep disturbances and
psychiatric disorders. An opportunity for
prevention?JAMA. 1989 Sep 15262(11)1479-84.
52
Sleep complaints in mood disorders
  • Initial insomnia
  • Frequent/extended wakening
  • EMW
  • Vivid dreams, -ve emotional content
  • Lack of adequate rest
  • Hypersomnia (BPAD depressed, SAD)
  • Reduced sleep (mania)

(MDD)
53
Subjective effects of AD on sleep
  • Few good studies
  • Mismatch between subjective sleep and objective
    measure
  • AD may affect subjective sleep

54
Polysomnography findings MDD
  • Initiation and maintenance
  • ?sleep latency
  • Frequent awakenings
  • EMW
  • Reduced SWS
  • Absolute and relative
  • Fewer delta waves
  • REM
  • Reduced REM latency
  • ?REM in first half night
  • More eye movements

55
Polysomnography in at-risk population
  • Two 1st degree relatives with MDD
  • Reduced SWS in first NREM sleep cycle
  • Increased REM density first REM period

J Affect Dis 2001 6233-
56
Functional imaging depression
  • REM
  • Increased activation wake vs sleep
  • Midbrain reticular formation
  • L hemisphere cortical regions (DLPFC, FEF)
  • Limbic/paralimbic regions (hipp, basal
    forebrain, ACC, MPFC)
  • NREM
  • Increased whole brain metabolism

57
BPAD dysthymia
  • BPAD
  • Similar findings to MDD (depressed manic)
  • Dysthymia
  • Minimal changes

58
Treatment effects
  • Pharmacological tx most effective in pt with
    sleep architecture disturbance

Which depressed patients will respond to
interpersonal psychotherapy? The role of
abnormal EEG sleep profiles.Am J Psychiatry.
1997 Apr154(4)502-9.
59
SSRI effects on REM
  • Reduced REM
  • Increased REM latency
  • Effects within 2-3 days
  • effects mediated ? synaptic 5HT
  • ?5HT1A
  • 1A knockout mice no effect of citalopram on REM
    latency
  • 5HT1a agonists reduce REM
  • Tryptophan depletion removes SSRI REM effect

60
SSRI effects SWS
  • Increased time Stage1
  • Increased awakenings
  • Increased time awake
  • Effects diminish over 5/7 (except fluoxetine)
  • ?5HT2 mediated
  • Agonists disturb sleep
  • Antagonists promote sleep

61
TCA effects
  • REM similar to SSRI
  • SWS
  • imipramine, clomipramine, desipramine increased
    sleep fragmentation
  • Amitriptyline improve sleep healthy volunteers,
    not in MDD
  • ? 5HT2 antagonism effect

62
MAOI
  • REM
  • Phenelzine complete REM suppression
  • 5HT mechanism- reversed by tryp. depl.
  • ?MAOB effect
  • Moclobemide minimal effect
  • SWS
  • Increased sleep fragmentation

63
Other AD
  • Mianserin
  • Suppressed REM
  • Reduced SWS fragmentation (?H1 blockade)
  • Mirtazepine, trazadone, nefazadone
  • Increased REM onset latency
  • Reduced fragmentation (5HT2 antagonism)
  • Reboxetine
  • Minimal effect on REM or SWS
  • Venlafaxine
  • SSRI like effects

64
Other AD
  • Agomelatine
  • 5HT2c antagonist
  • MT1/ MT2 agonist
  • Effective AD (antidepressant efficacy of
    agomelatine meta-analysis of published and
    unpublished studies BMJ 2014348g1888)
  • Increased SWS, reduced sleep latency
  • No effects on REM latency, total REM or REM
    densityThe International Journal of
    Neuropsychopharmacology (Impact Factor 5.64).
    11/2007 10(5)691-6.

65
Effects of AD on HAM-D sleep items
Drugs. 200565(7)927-47.
66
Change in perception of sleep quality with
nefazadone
Psychiatry Res. 2003 Sep 30120(2)179-90.
67
AD adverse effects on sleep
  • Restless legs
  • Eye-movements in SWS
  • Bruxism
  • Nightmares
  • Withdrawal nightmares

68
Sleep deprivation effects
  • One study
  • 123IIBZM SPET
  • Increased DA release after sleep deprivation

69
Sleep and schizophrenia
  • Rarely predominant complaint
  • Disturbance may precede relapse
  • Insomnia occasionally very severe
  • Studies contradictory
  • Variety of definitions of schizophrenia
  • Older patients included
  • Medicated patients

70
Unmedicated patients
  • Stage 2 latency increased
  • Increased nocturnal wakenings
  • Reduced sleep efficiency
  • ? REM latency reduced

71
Medicated patients- typical antipsychotics
  • Stage 2 latency increased
  • Reduced stage 2 4
  • Total sleep time reduced
  • Reduced sleep efficiency
  • Reduced REM latency
  • Reduced total REM sleep

72
Medicated patients- atypical antipsychotics I
  • Olanzapine
  • Increased total sleep
  • Increased sleep efficiency
  • Reduced stage 2 latency
  • Reduced total REM
  • Risperidone
  • Minimal data
  • Increased SWS

73
Medicated patients- atypical antipsychotics II
  • Clozapine
  • Increased total sleep
  • Increased sleep efficiency
  • No effect on REM
  • ? Rebound insomnia after abrupt stop
Write a Comment
User Comments (0)
About PowerShow.com